Metformin (open-label)

DRUG3 trials

Sponsors

AstraZeneca, Merck Sharp & Dohme LLC, Medical College of Wisconsin

Conditions

Bronchopulmonary Dysplasia (BPD)Type 2 DiabetesType 2 Diabetes Mellitus

Early Phase 1

Metformin for Premature Infants With Bronchopulmonary Dysplasia

RecruitingNCT07120971

Medical College of WisconsinBronchopulmonary Dysplasia (BPD)

Start: 2025-12-19End: 2030-09-01Target: 40Updated: 2026-01-26

Phase 3

A Study Assessing Saxagliptin Treatment in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise

CompletedNCT00374907

AstraZenecaType 2 Diabetes

Start: 2006-09-30End: 2009-12-31Updated: 2015-05-07

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

TerminatedNCT01477853

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2011-10-24End: 2012-12-04Updated: 2018-07-26